Czechia vs Egypt: The number of people with susceptibility test result for rifampicin
Czechia
89.51
in 2021
Egypt
89
in 2021
Czechia rank
68th
Egypt rank
71st
The number of people with susceptibility test result for rifampicin over time
- Czechia
- Egypt
How they compare
Czechia currently reports 89.51 against 89 in Egypt, a difference of 0.51.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Czechia ahead.
Czechia ranks 68th and Egypt ranks 71st of 146 countries.
Czechia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Czechia | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 86.46 | 66.01 | 20.45 | Czechia |
| 2020s | 87.15 | 87.01 | 0.141 | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Czechia or Egypt?
- Czechia, at 89.51 against 89 in Egypt as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Czechia and Egypt?
- 0.51, with Czechia ahead.
- How many years of comparable data are there for Czechia and Egypt?
- 5 years are reported by both, from 2017 to 2021.
- How do Czechia and Egypt rank globally for the number of people with susceptibility test result for rifampicin?
- Czechia ranks 68th and Egypt ranks 71st of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.